CAS No. 1313237-76-1

2-(3-(bromomethyl)phenyl)-5-methyloxazole

Identification

Catalog number	2236483
Chemical name	2-(3-(bromomethyl)phenyl)-5-methyloxazole
CAS RN	1313237-76-1
Molecular formula	C11H10BrNO

Structure

Classification

Send Inquiry Safety information

About 2-(3-(bromomethyl)phenyl)-5-methyloxazole

2-(3-(bromomethyl)phenyl)-5-methyloxazole is a chemical compound registered under CAS number 1313237-76-1, with the molecular formula C11H10BrNO and a molecular weight of about 252.1 g/mol. CMSTrade supplies 2-(3-(bromomethyl)phenyl)-5-methyloxazole for laboratory research and bulk production; product code 2236483. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 1313237-76-1
Molecular Formula: C11H10BrNO
Molecular Weight: 252.1 g/mol

Related Keywords

bromomethyl

methyloxazole

Oxazole

Pyridine, 2-(di-1H-imidazol-1-ylphenylmethyl)-

Piperazine,1-(3,5-dimethoxyphenyl)-4-[(3-methyl-1-phenyl-1H-pyrazol-5-yl)carbonyl]-

Pyridine, 2,3,4,5-tetrahydro-2,6-diphenyl-

Pyridine, 2,3-dihydro-2-[2-(1-naphthalenyl)-1-hexenyl]-

Piperazine,1-(3,5-dimethoxyphenyl)-4-[(1-phenyl-1H-pyrazol-5-yl)carbonyl]-

Pyridine, 2-(5-hexenyloxy)-5-(1H-imidazol-1-yl)-

502650-00-2

Pyridine, 2,3,4,5-tetrahydro-6-[(phenylmethyl)thio]-

Piperazine,1-(3,5-dimethoxyphenyl)-4-[[3-(3-hydroxy-1-pyrrolidinyl)-1-phenyl-1H-pyrazol-5-yl]carbonyl]-

Piperazine,1-(3-chlorophenyl)-4-[(3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl]-,mono(trifluoroacetate)

(5E)-5-(3,5-dichloro-4-methoxybenzylidene)-1-(4-methylphenyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione

Piperazine,1-(3-methylphenyl)-4-[(3-methyl-1-phenyl-1H-pyrazol-5-yl)carbonyl]-

Pyridine, 2,4,6-triphenyl-3-(2-propenyl)-, compd. with2,4,6-trinitrophenol

105998-92-3

Piperazine,1-(4-chloro-3-methoxyphenyl)-4-[[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-

Pyridine, 2,3,4,5-tetramethyl-, 1-oxide

Piperazine,1-(3-chlorobenzoyl)-4-[4-[[6-methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl]carbonyl]phenyl]-

Pyridine, 2-(4-piperidinyl)-, 1-oxide

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-[(2-methylpropyl)amino]-5-(methylsulfonyl)benzoyl]-

Pyridine, 2-(5-phenyl-1,2,4-oxadiazol-3-yl)-

13389-61-2

Piperazine,1-(4-chloro-3-methoxyphenyl)-4-[[4-chloro-5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-

Pyridine, 2,3-dihydro-2-[2-(4-methoxyphenyl)-1-hexenyl]-

Piperazine,1-(3-chlorophenyl)-4-[[1-(3-cyanophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]carbonyl]-

Piperazine,1-(3-cyclopentyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-4-(4-propoxybenzoyl)-, mono(trifluoroacetate)

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-[(2S)-2-(methoxymethyl)-1-pyrrolidinyl]-5-nitrobenzoyl]-

Piperazine,1-(3,5-dimethoxyphenyl)-4-[[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-5-yl]carbonyl]-

756752-69-9

N-hydroxy-1-(6-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazol-5-yl)methanimine

Piperazine,1-(4-chloro-3-methoxyphenyl)-4-[[4-chloro-5-methyl-3-(5-pyrimidinyl)-1H-pyrazol-1-yl]acetyl]-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-(cyclohexylmethylamino)-5-nitrobenzoyl]-

Pyridine, 2,3-dimethyl-4,5,6-triphenyl-

Piperazine,1-(3,5-dimethoxyphenyl)-4-[[1-phenyl-3-(1H-pyrrol-2-yl)-1H-pyrazol-5-yl]carbonyl]-

Piperazine,1-(4-chloro-3-methoxyphenyl)-4-[(4-chloro-5-methyl-3-phenyl-1H-pyrazol-1-yl)acetyl]-

740807-56-1

Cyclopentane, 1,1'-(1-methylene-1,3-propanediyl)bis-

Polyphosphoric acids, 2,3-dibromopropyl esters, ammonium salts

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-(methylsulfonyl)benzoyl]-

Piperazine,1-(4-chloro-3-methoxyphenyl)-4-[[4-chloro-5-methyl-3-(2-thienyl)-1H-pyrazol-1-yl]acetyl]-

Imidazo[5,1-a]isoquinoline-1-carboxamide,N-[2-(dimethylamino)ethyl]-5,6-dihydro-8,9-dimethoxy-3-methyl-,monohydrochloride

Piperazine,1-(3-cyclopentyl-1-oxopropyl)-4-[3-(1H-indol-3-yl)-1-oxo-2-[[[[4-(trifluoromethyl)phenyl]amino]carbonyl]amino]propyl]-2-methyl-